Japan approves first and only facilitated subcutaneous immunoglobulin for Agammaglobulinemia and Hypogammaglobulinemia

Takeda has announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of HYQVIA [Immun...

January 5, 2025 | Sunday | News
Japan's Fujirebio and Eisai to establish diagnostic technologies for various neurodegenerative diseases

Fujirebio Holdings, a wholly-owned subsidiary of H.U. Group Holdings, Inc., and Eisai Co., in Japan, have entered into a...

December 24, 2024 | Tuesday | News
Japan's Sumitomo to establish regenerative medicine and cell therapy joint venture

Japan's Sumitomo Chemical Co. and Sumitomo Pharma have studied restructuring measures to accelerate the development of r...

December 20, 2024 | Friday | News
Takeda, Tohoku University form alliance to strengthen drug discovery capabilities in Japan

Takeda Pharmaceutical Company and the Tohoku University Drug Discovery Strategy Promotion Organization have entered into...

December 18, 2024 | Wednesday | News
Japan's Shimadzu develops platform to support gene therapy manufacturing

Japan-based Shimadzu Corporation has signed an investment contract with U-Medico Inc, a contract research organisation (...

December 17, 2024 | Tuesday | News
Eisai Subsidiary inks €117 M deal for schizophrenia treatment in Japan and other Asian territories

Newron Pharmaceuticals, a biopharmaceutical company focused on the development of novel therapies for patients with dise...

December 16, 2024 | Monday | News
TMC Japan BioBridge to provide Japanese healthcare innovators path to enter US market

Texas Medical Center (TMC), in the US, in partnership with Japan-based organisations Mitsui Fudosan Co. and&nb...

December 10, 2024 | Tuesday | News
Israel's Teva Pharma to divest business venture in Japan

Israel-based Teva Pharmaceutical Industries has entered into an agreement with JKI, established by the fund managed and ...

December 6, 2024 | Friday | News
SOHM, Inc. secures key patent in Japan for revolutionary gene editing technology

SOHM, Inc., a globally recognised pharmaceutical company focused on developing, manufacturing and distributing Generic, ...

November 27, 2024 | Wednesday | News
Eisai and Biogen Japan collaborate to lead dementia genomics R&D with NCNP in Japan

Eisai Co., Ltd. and Biogen Japan Ltd. have announced that Eisai has entered into a research collaboration agreement with...

November 26, 2024 | Tuesday | News
IIT Roorkee and Kyoto University open joint-research lab in Japan with focus on healthy ageing

The Indian Institute of Technology (IIT) Roorkee and Kyoto University have announce the inauguration of a joint research...

November 25, 2024 | Monday | News
Kura Oncology & Kyowa Kirin ink billion dollar deal to develop and commercialise Ziftomenib for acute leukemia treatment

US-based Kura Oncology, Inc. and Japanese pharmaceutical firm Kyowa Kirin have entered into a global strategic collabora...

November 23, 2024 | Saturday | News
Singleron Joins Forces with TOMY Digital Biology to Transform Single Cell Analysis in Japan

Singleron Biotechnologies, a leader in single cell analysis solutions, has announced a new distributor partnership with ...

November 20, 2024 | Wednesday | News
Kaken Pharmaceutical and Numab Therapeutics collaborate on inflammatory bowel disease treatment

Numab Therapeutics AG, a clinical stage biotechnology company advancing a proprietary pipeline of multi-specific antibod...

November 15, 2024 | Friday | News
Meiji Seika Pharma invests in ARCALIS to boost production of mRNA vaccines in Japan

Japan-based Meiji Seika Pharma Co. has announced its investment in ARCALIS, Inc. which is a joint venture between Axcele...

November 18, 2024 | Monday | News
Japan’s GHIT Fund invests $4 M to advance diagnostics and treatments for NTDs and malaria

Japan-based Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 578 mi...

November 8, 2024 | Friday | News
Inocras and Summit Pharma International Corp collaborate to transform clinical genomics in Japan

US-based Inocras Inc. and Summit Pharmaceuticals International Corporation have signed a Memorandum of understanding (Mo...

November 6, 2024 | Wednesday | News
Japan Agency for Medical Research and Development picks Eisai's venture capital to strengthen program for pharma startup ecosystem

Eisai Co. and Eisai’s corporate venture capital subsidiary, Eisai Innovation, Inc. have announced that Eisai Innov...

November 5, 2024 | Tuesday | News